Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Consun Pharmaceutical Group Ltd. ( (HK:1681) ) has shared an update.
Consun Pharmaceutical Group Ltd. has announced that its subsidiaries have subscribed to wealth management products from SPD Bank and its subsidiary, SPDB Wealth Management, with a total principal amount of RMB875,500,000. These transactions, funded by the company’s idle funds, are considered discloseable under Hong Kong’s Listing Rules due to their aggregated value exceeding certain percentage thresholds, though they do not require shareholder approval.
The most recent analyst rating on (HK:1681) stock is a Buy with a HK$10.00 price target. To see the full list of analyst forecasts on Consun Pharmaceutical Group Ltd. stock, see the HK:1681 Stock Forecast page.
More about Consun Pharmaceutical Group Ltd.
YTD Price Performance: 69.82%
Average Trading Volume: 2,553,556
Technical Sentiment Signal: Buy
Current Market Cap: HK$11.23B
Learn more about 1681 stock on TipRanks’ Stock Analysis page.